Kari Gillmeyer

Kari Gillmeyer

Boston University

H-index: 5

North America-United States

About Kari Gillmeyer

Kari Gillmeyer, With an exceptional h-index of 5 and a recent h-index of 5 (since 2020), a distinguished researcher at Boston University, specializes in the field of Pulmonary hypertension, health services research, care coordination.

His recent articles reflect a diverse array of research interests and contributions to the field:

Outpatient Evaluation and Follow-Up of Veterans with Group 3 Pulmonary Hypertension Treated with Phosphodiesterase-5-Inhibitors

Baseline Assessment and Follow Up of Veterans with Groups 2 and 3 Pulmonary Hypertension Treated with Vasodilator Therapy: A Qualitative Study

Development and validation of algorithms to identify pulmonary arterial hypertension in administrative data

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease

Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19) Study Protocol

Novel Therapeutic Approaches for Pulmonary Manifestations of Systemic Sclerosis

How Closely Do Clinical Trial Participants Resemble “Real-World” Patients with Groups 2 and 3 Pulmonary Hypertension? A Structured Review

Factors associated with potentially inappropriate phosphodiesterase-5 inhibitor use for pulmonary hypertension in the United States, 2006 to 2015

Kari Gillmeyer Information

University

Position

___

Citations(all)

68

Citations(since 2020)

68

Cited By

22

hIndex(all)

5

hIndex(since 2020)

5

i10Index(all)

2

i10Index(since 2020)

2

Email

University Profile Page

Google Scholar

Kari Gillmeyer Skills & Research Interests

Pulmonary hypertension

health services research

care coordination

Top articles of Kari Gillmeyer

Outpatient Evaluation and Follow-Up of Veterans with Group 3 Pulmonary Hypertension Treated with Phosphodiesterase-5-Inhibitors

2021/5

Baseline Assessment and Follow Up of Veterans with Groups 2 and 3 Pulmonary Hypertension Treated with Vasodilator Therapy: A Qualitative Study

2021/5

Development and validation of algorithms to identify pulmonary arterial hypertension in administrative data

Canadian Journal of Cardiology

2023/5/1

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease

Pulmonary Circulation

2021/3

Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19) Study Protocol

Annals of the American Thoracic Society

2021/3/1

Novel Therapeutic Approaches for Pulmonary Manifestations of Systemic Sclerosis

American Journal of Respiratory and Critical Care Medicine

2020/9/15

How Closely Do Clinical Trial Participants Resemble “Real-World” Patients with Groups 2 and 3 Pulmonary Hypertension? A Structured Review

2020/6

Factors associated with potentially inappropriate phosphodiesterase-5 inhibitor use for pulmonary hypertension in the United States, 2006 to 2015

Circulation: Cardiovascular Quality and Outcomes

2020/5

Outcomes of Pulmonary Vasodilator Use in a National Cohort of Veterans with Pulmonary Hypertension Associated with Left Heart Disease and Lung Disease

2020/5

See List of Professors in Kari Gillmeyer University(Boston University)

Co-Authors

academic-engine